Fact CheckerSign in

NCT07419074Completed

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

Source: ClinicalTrials.gov · Last updated 18 Feb 2026

Brief summary (registry, in English)

Garcinia cambogia, rich in hydroxycitric acid (HCA), has been suggested to promote weight loss and improve metabolic parameters. Evidence regarding its efficacy in pre-diabetic obese adults remains limited. Objective: To evaluate the effects of Garcinia cambogia rind powder supplementation on anthropometric, glycemic, lipid, hepatic, and renal parameters in pre-diabetic obese adults.

Status (registry)
Completed
Study type
Interventional
Enrollment
90 (actual)
First submitted
11 Feb 2026
Start date
Sept 2025
Primary completion date
Nov 2025
Lead sponsor
University of Lahore
Diseases
Obesity
NCT number
NCT07419074

What you commit to

  • Study type: Interventional
  • Participants enrolled: 90
  • From Sept 2025 to the primary completion date, Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • chronic liver, kidney, or cardiovascular disease,
  • history of hepatotoxicity or gastrointestinal disorders,
  • using weight-loss supplements, steroids, or lipid-lowering drugs, or had a known allergy to Garcinia cambogia

Other

  • Participants who were diagnosed with type 1, pregnant or lactating,

Who the study is looking for

  • Participants of both genders were included if they were aged 30-60 years,
  • body mass index (BMI) ≥30 kg/m²,
  • Individuals with HbA1c levels ranging from 5.7% to 10% were selected, .indicating pre-diabetic to diabetic status. Participants were required to have a .body mass index (BMI) of 25 kg/m² or higher

Age in the registry: 30 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sana Noreen
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.